Wild Days Are Ahead on Wall Street

Earn While You Learn! ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ [EARN WHILE YOU LEARN! JOIN OUR FREE LIVE TRADING SESSION!]( Hello investor, Wild Days Are Ahead on Wall Street The market is hovering around all-time highs. However, it refuses to break out or pull back around the current level. We are at a standstill, and will likely remain deadlocked for one more day until after the presidential election. Wall Street would typically try to get ahead of the game to exploit potential price discrepancies before key events. Not this time. The reason is simple — the presidential election is simply too hotly contested. It is basically a coin flip right now. There is still a possibility that the result will be challenged, adding uncertainty to the market. The Federal Reserve will also announce its interest rate decision on Thursday. (The central bank chose to delay its decision by one day due to the election.) (Photo: Olivier Douliery/Bloomberg via Getty Images) Many analysts thought Big Tech earnings could move the market to a new direction. It didn’t. Investors largely sat still. Things could change once they get more clarifications from the presidential election and the central bank’s future interest rate path. Notably, the fear gauge VIX has been rising lately while the S&P 500 hit record highs. It indicated that the jitters were high. Even corporate insiders have avoided buying shares, with the buy-sell ratio being at the second-lowest level since the spring of 2021. Despite these potential risks, the fundamentals haven’t changed. The economy is strong. Earnings keep growing. Inflation is cooling. The central bank is cutting rates. So, Mark Luschini at Janney Montgomery Scott urges investors to focus on what the economy could look like “six to 18 months from now” and avoid worrying too much about what could happen tomorrow. - “If it was a cleaner call, it would be baked into the market and there would be little left to exploit,” said Mark Luschini, chief investment strategist at Janney Montgomery Scott. - “But in something this tight it is better to look over the horizon and maintain your thoughts on what the macroeconomic condition will look like six to 18 months from now, rather than just on the outcome on that day.” The next few days are poised to be wild on Wall Street. Get ready, traders. Top Dental Stock to Own Right Now Today’s Stock Pick: ZimVie (ZIMV) Tooth can be a wonderful business to be in. The reason is simple — everybody has teeth! ZimVie is a pure play in the dental space, and there are multiple reasons why it is an attractive stock to own right now. There are 8 million U.S. patients seeking treatment for tooth loss annually. The last word is key — annually. Since they just lost a tooth or two, they will need to replace them. However, only 25% receive tooth replacement. This offers a robust opportunity for ZimVie to expand its market by offering tooth replacements to more patients. (Source: ZimVie) ZimVie offers premium implants, restorative implant solutions, biomaterials solutions, and digital dentistry technologies. Implants are straightforward, as they are the product that inserts inside a patient’s gum, holding the synthetic tooth. (Source: ZimVie) Biomaterials include bone graft substitutes, membranes, and tissue regenerative products. (Source: ZimVie) Finally, its digital dentistry business offers different technologies to help dentists plan, design, and execute procedures. (Source: ZimVie) Recently, ZimVie sold its spine business for $375 million to become a pure-play dental company. As a result, the company has a clear focus to maintain (and grow) its leadership position in the $8 billion implant, digital solutions, and biomaterials market. Its digital offerings can be the big growth catalyst in the years ahead. The company estimates that only about 20% of dental implant cases are performed using the complete digital workflow. And there’s no reason not to go digital. Those dental practices that adopt ZimVie’s digital workflow solutions end up performing more implant cases than those that don’t. To maintain its leadership in the market, ZimVie built a training center to educate clinicians about the field of implantology. It has a fully-integrated digital workflow with 3D printing and RealGUIDE software. As a result, those clinicians who were trained at the Institute may be more likely to purchase ZimVie’s products because they were trained for these products. (Source: ZimVie) What’s more, the company expects to improve margins by reducing corporate overhead, IT, and legal costs and automating manufacturing operations. Meaning? There could be extra EPS growth down the road. (Source: ZimVie) Wall Street expects ZimVie to grow its EPS by 13% next year, which is somewhat solid. (Source: Yahoo Finance) Bottom line: ZimVie was in the news in July due to a rumor that Osstem submitted a final bid to buy ZimVie. It offers an upside that the company could be bought at a higher valuation than its market cap, and its solid earnings growth gives it another potential catalyst for price appreciation.   [EARN WHILE YOU LEARN! JOIN OUR FREE LIVE TRADING SESSION!](     © All Rights Reserved, Trade Alliance [Unsubscribe]( | [Manage Preferences](